Skip to main content
. 2013 Jan 30;3:844. doi: 10.1038/srep00844

Figure 5. Scaffold structures of control compound and TCM candidates.

Figure 5

(a) the alpha-ketoheterocycle inhibitor (9Z)-1-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)octadec-9-en-1-one (control), and TCM candidates (b) Guineensine and Retrofractamide A. Guineensine and Retrofractamide A differ in the number of carbons found in the hydrophobic tail region. The number of carbons for Guineensine is depicted in blue and that for Retrofractamide A is depicted in gray.